[ad_1] RoboStrategy (BOT) is attracting attention because it offers something public-market investors rarely get: direct exposure to private robotics and embodied-AI names through a listed vehicle. The company recently said its common stock had begun trading on Nasdaq under the…
[ad_1] Image source: Getty Images Over the last week, NatWest (LSE: NWG) shares have been in demand. The FTSE 100 bank is the most bought stock on the AJ Bell investment platform. It’s even outstripped growth superheroes Rolls-Royce and Nvidia, languishing in seventh…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage Earnings Flash Edible Garden AG Stock Rallies 30% on Q1 2026 Surging Revenue May 15, 2026 Breaking News Edible Garden AG Releases Q1 2026 Financial Results May 15, 2026 EDBL|Loss Per…
[ad_1] Image source: Getty Images Getting passive income going from the stock market in 2026 is pretty straightforward. Due to the digital revolution, you can open and fund an investing account on a smartphone in no time at all. However,…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Coinbase Global shares tumbled Friday, falling 8.6% to $193.75 after Baird slashed its price target and downgraded its stance on the crypto exchange operator. The stock declined on elevated volume of 6.7M shares…
[ad_1] Image source: Getty Images When considering the type of growth stocks that the UK is famous for, your mind perhaps goes to finance or pharma. These sectors are what Britain is known for in the modern day. The prospect…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence EDBL|EPS -$5.25|Rev $3.3M|Net Loss $3.7M Stock $0.53 (+30%) In-Line Performance. Edible Garden AG Incorporated (NASDAQ:EDBL) delivered Q1 2026 revenue of $3.3M that matched Wall Street’s consensus estimate, while reporting a loss per share…
[ad_1] Image source: Getty Images Too many investors underrate UK shares. Some think they’re a little dull compared to those giant US tech mega-caps. Could that be their superpower? Alexandra Jackson, director of equities at Rathbones Asset Management, says if…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence SPRY|EPS -$0.61 vs -$0.51 est (-19.6%)|Rev $22.7M|Net Loss $60.6M ARS Pharmaceuticals, Inc. reported a wider-than-expected loss for Q1 2026 as the biopharmaceutical company continued investing heavily in commercializing its severe allergic reaction treatment.…
[ad_1] Image source: Getty Images To say Greggs‘ (LSE:GRG) shares have been lukewarm in recent years would be an understatement. Down 40% in the past 36 months, this FTSE 250 stock has served up returns best described as a soggy…